Tag: RelabotulinumtoxinA
Galderma boosts biologics manufacturing with new Swedish licence approvals
Galderma has secured manufacturing license updates from the Swedish Medical Products Agency, enabling the company to advance its ambitious growth and innovation agenda.
Featured Article
Smarter energy decisions: GridBeyond unveils AI-powered Bid Optimiser in Australia
As Australia’s energy transition accelerates, businesses participating in the National Electricity Market (NEM) are facing growing challenges in managing their energy assets efficiently.
